Brimonidine-d4 D-Tartrate

Product Name Brimonidine-d4 D-Tartrate
Alternate Names Brimonidine Stable Isotopes, Stable Isotopes of Brimonidine
CAT No. CS-B-00072
CAS No. 70359-46-5(unlabeled)
Category Stable Isotopes
Stock IN-Stock
Mol. Wt. 446.25 g/mol
Mol. For. C₁₅H₁₂D₄BrN₅O₆
Hazardous This is a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Parent API Brimonidine
Smileys O[C@@H](C(O)=O)[C@@H](O)C(O)=O.BrC(C1=NC=CN=C1C=C2)=C2NC3=NC([2H])([2H])C([2H])([2H])N3
Canonical Smiles C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O
InchIKey QZHBYNSSDLTCRG-LREBCSMRSA-N
Inchl InChI=1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
IUPAC 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine;(2R,3R)-2,3-dihydroxybutanedioic acid
Controlled No
Shipping Free for purchase above 1000$
Delivery In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email sales@clearsynth.com
Brimonidine-d4 D-Tartrate is a medication that is used to treat glaucoma and ocular hypertension. It is a selective alpha-2 adrenergic receptor agonist that reduces intraocular pressure by decreasing the production of aqueous humor and increasing the outflow of aqueous humor. Brimonidine-d4 D-Tartrate is available in the form of eye drops and is administered directly to the affected eye. The chemical formula of Brimonidine-d4 D-Tartrate is C11H10D4BrN5.C4H6O6, and it has a molecular weight of 442.32 g/mol. It is a deuterated form of Brimonidine Tartrate, which means it has four hydrogen atoms replaced with deuterium atoms. Brimonidine-d4 D-Tartrate is a prescription medication and should only be used under the guidance of a healthcare professional. It is not recommended for use in children under the age of 2 years old, and caution should be exercised in patients with cardiovascular or cerebrovascular disease, depression, or Raynaud's phenomenon. The most common side effects of Brimonidine-d4 D-Tartrate include ocular hyperemia, burning sensation, foreign body sensation, and blurred vision. Serious side effects are rare but can include allergic reactions, bradycardia, and hypotension. In conclusion, Brimonidine-d4 D-Tartrate is an effective medication for treating glaucoma and ocular hypertension. It works by reducing intraocular pressure and increasing the outflow of aqueous humor. It is important to follow the dosage and administration instructions provided by a healthcare professional to ensure safe and effective use of this medication.

This page contains information about Brimonidine-d4 D-Tartrate. You can buy Brimonidine-d4 D-Tartrate from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Brimonidine-d4 D-Tartrate